Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

cGMP via PKG activates 26S proteasomes and enhances degradation of proteins, including ones that cause neurodegenerative diseases
Jordan J. S. VerPlank, Sylwia D. Tyrkalska, Angeleen Fleming, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 25, pp. 14220-14230
Open Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

The AAA+ chaperone VCP disaggregates Tau fibrils and generates aggregate seeds in a cellular system
Itika Saha, Patricia Yuste‐Checa, Miguel da Silva Padilha, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 46
Interplay of Proteostasis Capacity and Protein Aggregation: Implications for Cellular Function and Disease
Mark S. Hipp, F. Ulrich Hartl
Journal of Molecular Biology (2024) Vol. 436, Iss. 14, pp. 168615-168615
Open Access | Times Cited: 17
Advances of Zebrafish in Neurodegenerative Disease: From Models to Drug Discovery
Xiaobo Wang, Jinbao Zhang, Kaijie He, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 76
The proteasome and its role in the nervous system
Fulya Türker, Emily K. Cook, Seth S. Margolis
Cell chemical biology (2021) Vol. 28, Iss. 7, pp. 903-917
Open Access | Times Cited: 62
Neuromodulatory effect of vardenafil on aluminium chloride/d-galactose induced Alzheimer’s disease in rats: emphasis on amyloid-beta, p-tau, PI3K/Akt/p53 pathway, endoplasmic reticulum stress, and cellular senescence
Heba H. Awad, Mahmoud A. Desouky, Alaa Zidan, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 5, pp. 2653-2673
Open Access | Times Cited: 26
Advances in Zebrafish as a Comprehensive Model of Mental Disorders
Lei Wang, Fan Liu, Yimeng Fang, et al.
Depression and Anxiety (2023) Vol. 2023, pp. 1-48
Open Access | Times Cited: 24
Abnormal protein post-translational modifications induces aggregation and abnormal deposition of protein, mediating neurodegenerative diseases
Wei Li, Honglian Li, Jian‐Zhi Wang, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 9
The dialogue between the ubiquitin-proteasome system and autophagy: Implications in ageing
Jia Liang Sun‐Wang, Saška Ivanova, António Zorzano
Ageing Research Reviews (2020) Vol. 64, pp. 101203-101203
Closed Access | Times Cited: 67
Small molecule therapeutics for tauopathy in Alzheimer’s disease: Walking on the path of most resistance
Lisha Wang, Bharti Bharti, Rajnish Kumar, et al.
European Journal of Medicinal Chemistry (2020) Vol. 209, pp. 112915-112915
Open Access | Times Cited: 66
EYA2 suppresses the progression of hepatocellular carcinoma via SOCS3-mediated blockade of JAK/STAT signaling
Ze-Kun Liu, Can Li, Renyu Zhang, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 43
Zebrafish and Medaka: Important Animal Models for Human Neurodegenerative Diseases
Jing Wang, Hong Cao
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10766-10766
Open Access | Times Cited: 43
Person‐specific differences in ubiquitin‐proteasome mediated proteostasis in human neurons
Yi‐Chen Hsieh, Zachary M. Augur, Mason Arbery, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 4, pp. 2952-2967
Open Access | Times Cited: 7
High Mobility Group Box Protein (HMGB1): A Potential Therapeutic Target for Diabetic Encephalopathy
Udit Kumar Dash, Debashree Mazumdar, Santosh Singh
Molecular Neurobiology (2024) Vol. 61, Iss. 10, pp. 8188-8205
Closed Access | Times Cited: 7
Mechanisms That Activate 26S Proteasomes and Enhance Protein Degradation
Alfred L. Goldberg, Hyoung Tae Kim, Dong Hoon Lee, et al.
Biomolecules (2021) Vol. 11, Iss. 6, pp. 779-779
Open Access | Times Cited: 37
Moonlighting Proteins Shine New Light on Molecular Signaling Niches
Ilona Turek, Helen Irving
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1367-1367
Open Access | Times Cited: 36
Compounds activating VCP D1 ATPase enhance both autophagic and proteasomal neurotoxic protein clearance
Lidia Wróbel, Sandra Malmgren Hill, Alvin Djajadikerta, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 26
Phosphodiesterase 5 inhibitor mirodenafil ameliorates Alzheimer-like pathology and symptoms by multimodal actions
Byung Woo Kang, Fred Kim, Joon‐Yong Cho, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 25
Zebrafish as a Model Organism for Studying Pathologic Mechanisms of Neurodegenerative Diseases and other Neural Disorders
Yanying Liu
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 6, pp. 2603-2620
Closed Access | Times Cited: 14
Activators of the 26S proteasome when protein degradation increases
Dong Hoon Lee
Experimental & Molecular Medicine (2025)
Open Access
Phosphodiesterase 4D inhibition improves the functional and molecular outcome in a mouse and human model of Charcot Marie Tooth disease 1 A
Melissa Schepers, Tim Vangansewinkel, Karen Libberecht, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 183, pp. 117828-117828
Open Access
Proteomic and Metabolomic Profiling Nominates Druggable Targets and Biomarkers for Pulmonary Arterial Hypertension-Associated Myopathy and Exercise Intolerance
Phablo Abreu, Ryan Moon, Jenna B. Mendelson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
CHIP phosphorylation by protein kinase G enhances protein quality control and attenuates cardiac ischemic injury
Mark J. Ranek, Christian U. Oeing, Rebekah Sanchez‐Hodge, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 37
PAC1 receptor–mediated clearance of tau in postsynaptic compartments attenuates tau pathology in mouse brain
Ari W. Schaler, Avery M. Runyan, Catherine L. Clelland, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 595
Open Access | Times Cited: 31
Oxidative Damage Induces a Vacancy G-Quadruplex That Binds Guanine Metabolites: Solution Structure of a cGMP Fill-in Vacancy G-Quadruplex in the Oxidized BLM Gene Promoter
Kai‐Bo Wang, Yushuang Liu, Yipu Li, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 14, pp. 6361-6372
Open Access | Times Cited: 21
Modulation of Inflammatory Cytokine Production in Human Monocytes by cGMP and IRAK3
Trang Hong Nguyen, Anna Axell, Ilona Turek, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2552-2552
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top